Abstract
The actual protocols for status epilepticus treatment, in general are inflexible, and only oriented for the treatment of generalized tonic clonic seizures. They do not consider the kind of seizures, epileptic syndrome, patient age or another patient comorbility. In this paper, base in status epilepticus cases; there is another treatment approach, having as reference seizures type, epileptic syndrome, patient age, comorbilities, and new intravenous antiepileptic drugs available.
References
RONA S, ROSENOW F, ARNOLD S, CARREÑO M, DIEHL B, EBNER A, FRITSCH B, HAMER HM, HOLTHAUSEN H, KNAKE S, KRUSE B, NOACHTAR S, PIEPER T, TUXHORN I, LUDERS HO. A semiological classification of status epilepti- cus. Epileptic disord 2005; 7:5-12
MAYOR LC, GODOY J, GONZÁLEZ W. Epilepsia y Síndromes convulsivos. En Toro J, Yepes Palacios
E. eds. Neurología. Segunda edición. Bogotá: Manual Moderno (Colombia), 2010: 201-253.
RABINSTEIN AA. Management of status epilepti- cus in adults. Neurolclin. 2010; 28: 853-862.
GILAD R, IZKOVITZ N, DABBY R, ET AL. Treatment of status epilepticus and acute repetitive seizures with I.V. valproic acid vs phenytoin. Acta- Neurolscand 2008; 118:296-300.
LIMDI NA, SHIMPI AV, FAUGHT E, ET AL. Effi- cacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005;64: 353-355.
BERNING S, BOESEBECK F, VAN BAALEN A, ET AL. Intravenous levetiracetam as treatment for status epilepticus. J Neurol 2009;256: 1634-1642.
CHOKSHI R, OPENSHAW J, MEHTA NN, MOHLER E. Purple glove syndrome following intra- venous phenytoin administration. Vascular Medicine. 2007; 12: 29-31
FATTOUCH J, DI BONAVENTURA C, CAS- CIATO S, BONINI F, PETRUCCI S, LAPENTA L, MANFREDI M, PRENCIPE M, GIALLONARDO AT. Intravenous Levtiracetam as first-line treatment of status epilepticus in the elderly. ActaNeurolScand 2010: 121: 418–421
AIGUABELLA-MERCE F, VILLANUEVA V, DE LA PEÑA P, MOLINS A, GARCIA-MORALES I, SAIZ R, PARDO J, TORTOSA D, SANSA G, MIRÓ J. Efficacy of intravenous Levetiracetam as an add-on tretament in status epilepticus: A multicentric obser- vational Study. Seizures 2011: 20: 60-64.
KOUBEISSI MZ, MAYOR CL, ESTEPHAN B, RASHID S, AZAR NJ. Efficacy and safety of intra- venous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 2011: 123: 142–146.
KELLINGHAUS C, BERNING S, IMMISCH I, LARCH J, ROSENOW F, ROSSETTI AO, TILZ C, TRINKA E. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand. 2011: 123: 137–141.
TILZ C, RESCH R, HOFER T, EGGERS C. Suc- cessful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010; 51(2):316-317.
GASTAUT H, ET AL. Treatment of status epilepti- cus with a new benzodiazepine more active tan diaz- epam. Epilepsia 1971; 12: 197-214.
CONGDON, ET AL. Intravenous clonazepam in the treatment of status epilepticus in children. Epilep- sia 1980; 21: 97-102.
CLAASEN J, HIRSCH LJ, EMERSON RG, ET AL. Continuous EEG monitoring and midazolam infusion for refractory noncovulsive status epilepti- cus. Neurology 2001; 57: 1036-1042.
NELIGAN A, SHORVON SD. Frequency and prognosis of convulsive status epilepticus of differ- ent causes. Arch Neurol. 2010; 67: 931-940.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.